| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8439350 | European Journal of Cancer | 2018 | 9 Pages |
Abstract
Observed PFS confirms that regorafenib warrants further clinical investigation in refractory non-adipocytic sarcomas.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Thomas Brodowicz, Olivier Mir, Jennifer Wallet, Antoine Italiano, Jean-Yves Blay, François Bertucci, Wolfgang Eisterer, Christine Chevreau, Sophie Piperno-Neumann, Emmanuelle Bompas, Thomas Ryckewaert, Bernadette Liegl-Antzwager, Julien Thery,